The only FDA approved therapeutic use of Endothelium-Derived Relaxing Factor is: (A) Pulmonary hypeension in newborn, (B) Primary pulmonary hypeension, (C) Congestive cardiac failure, (D) Essential hypeension in newborn
Answer is A. EDRF is also called nitric oxide. The only approved use is vasodilatation in Pulm.HTN in newborn Ref: Goodman Gillman 12thedPg 1059